Conclusion & References

Herpes simplex labialis is a common treatable viral infection that is a source of significant morbidity (pain, embarrassment, etc.). Treatment is effective and safe and, therefore, a prime target for pharmacist prescriptive protocols. Educating and empowering pharmacists to appropriately screen and assess individuals with Herpes simplex labialis can improve patient access to care and prevent adverse outcomes.


  1. Scott DA, Coulter WA, Lamey P-J. Oral shedding of herpes simplex virus type 1: a review. J Oral Pathol Med 1997;26(10):441-447.
  2. McQuillan G, Kruszon-Moran D, Flagg EW, Paulose-Ram R. Prevalence of Herpes Simplex Virus Type 1 and Type 2 in Persons Aged 14-49: United States, 2015-2016. NCHS Data Brief. 2018;(304):1-8.
  3. Corey L, Spear PG. Infections with herpes simplex viruses (1). N Engl J Med. 1986;314(11):686-691. doi:10.1056/NEJM198603133141105.
  4. Johnson RE, Nahmias AJ, Magder LS, Lee FK, Brooks CA, Snowden CB. A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med. 1989;321(1):7-12. doi:10.1056/NEJM198907063210102.
  5. Oliver L, Wald A, Kim M, et al. Seroprevalence of herpes simplex virus infections in a family medicine clinic. Arch Fam Med. 1995;4(3):228-232. doi:10.1001/archfami.4.3.228.
  6. Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. 2006;296(8):964-973. doi:10.1001/jama.296.8.964.
  7. . Accessed April 3, 2021.
  8. McMillan JA, Weiner LB, Higgins AM, Lamparella VJ. Pharyngitis associated with herpes simplex virus in college students. Pediatr Infect Dis J. 1993;12(4):280-284. doi:10.1097/00006454-199304000-00004.
  9. Spruance SL, Overall JC Jr, Kern ER, Krueger GG, Pliam V, Miller W. The natural history of recurrent Herpes simplex labialis: implications for antiviral therapy. N Engl J Med. 1977;297(2):69-75. doi:10.1056/NEJM197707142970201.
  10. Bhattarakosol P, Yoosook C, Cross A. Intratypic variation of herpes simplex virus type 2 isolates detected by monoclonal antibodies against viral glycoproteins. Arch Virol. 1990;115(1-2):89-100. doi:10.1007/BF01310625.
  11. Slomka MJ, Ashley RL, Cowan FM, Cross A, Brown DW. Monoclonal antibody blocking tests for the detection of HSV-1- and HSV-2-specific humoral responses: comparison with western blot assay. J Virol Methods. 1995;55(1):27-35. doi:10.1016/0166-0934(95)00042-s.
  12. Rooney JF, Bryson Y, Mannix ML, et al. Prevention of ultraviolet-light-induced herpes labialis by sunscreen. 1991;338(8780):1419-1422. doi:10.1016/0140-6736(91)92723-f.
  13. Alster TS, Nanni CA. Famciclovir prophylaxis of herpes simplex virus reactivation after laser skin resurfacing. Dermatol Surg. 1999;25(3):242-246. doi:10.1046/j.1524-4725.1999.08197.x.
  14. Openshaw H, Bennett HE. Recurrence of herpes simplex virus after dental extraction. J Infect Dis. 1982;146(5):707. doi:10.1093/infdis/146.5.707.
  15. . Accessed April 3, 2021.
  16. Roberts CM, Pfister JR, Spear SJ. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex Transm Dis. 2003;30(10):797-800. doi:10.1097/01.OLQ.0000092387.58746.C7.
  17. Martin ET, Krantz E, Gottlieb SL, et al. A pooled analysis of the effect of condoms in preventing HSV-2 acquisition [published correction appears in Arch Intern Med. 2010 Jun 14;170(11):929]. Arch Intern Med. 2009;169(13):1233-1240. doi:10.1001/archinternmed.2009.177.
  18. Amir J, Harel L, Smetana Z, Varsano I. Treatment of herpes simplex gingivostomatitis with aciclovir in children: a randomised double blind placebo controlled study. BMJ. 1997;314(7097):1800-1803. doi:10.1136/bmj.314.7097.1800.
  19. Abreva (docosanol) [prescribing information]. Moontownship, PA; February 2015.
  20. James SH, Whitley Treatment of herpes simplex virus infections in pediatric patients: current status and future needs. Clin Pharmacol Ther. 2010 Nov;88(5):720-724. doi: 10.1038/clpt.2010.192. Epub 2010 Sep 29. PMID: 20881952; PMCID: PMC3685871.
  21. Valtrex (valacyclovir) [prescribing information]. Research Triangle Park, NC: GlaxoSmithKline; December 2013.
  22. Lexi-Drugs. Hudson, OH: Lexicomp, 2015. Updated April 2, 2021. Accessed April 2, 2021
  23. Famvir (famciclovir) . Dorval, Quebec, Canada: Novartis Pharmaceuticals Canada Inc; September 2016.
  24. Lexi-Drugs. Hudson, OH: Lexicomp, 2015. Updated March 20, 2021. Accessed April 2, 2021
  25. Acyclovir (Systemic). Lexi-Drugs. Hudson, OH: Lexicomp, 2015. Updated March 27, 2021. Accessed April 2, 2021
  26. Lexi-Drugs. Hudson, OH: Lexicomp, 2015. Accessed April 13, 2021
  27. Sacks SL, Thisted RA, Jones TM, et al. Clinical efficacy of topical docosanol 10% cream for Herpes simplex labialis: A multicenter, randomized, placebo-controlled trial. J Am Acad Dermatol. 2001;45(2):222-230.
  28. Reid G, Jass J, Sebulsky MT, McCormick JK. Potential uses of probiotics in clinical practice. Clin Microbiol Rev. 2003;16(4):658-672.
  29. Godfrey HR, Godfrey NJ, Godfrey JC, Riley D. A randomized clinical trial on the treatment of oral herpes with topical zinc oxide/glycine. Altern Ther Health Med. 2001;7(3):49-56.
  30. Gaby AR. Natural remedies for Herpes simplex. Altern Med Rev. 2006;11(2):93-101.
  31. Schuhmacher A, Reichling J, Schnitzler P. Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro. Phytomedicine. 2003;10(6-7):504-510.
  32. Surjushe A, Vasani R, Saple DG. Aloe vera: a short review. Indian J Dermatol. 2008;53(4):163-166.
Close Bitnami banner